Enumeration of extracellular vesicles by a new improved flow cytometric method is comparable to fluorescence mode nanoparticle tracking analysis

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 4, 2016, Pages 977-986

  Pasalic, Leonardo ^a,b   Williams, Rebekka ^c   Siupa, Agnieszka ^d   Campbell, Heather ^a   Henderson, Michelle J ^c   Chen, Vivien M Y ^a,e,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Institute of Clinical Pathology and Medical Research   (Australia)

^c CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^d MALVERN INSTRUMENTS LTD   (United Kingdom)

^e Concord Repatriation and General Hospital ^*  (Australia)

^f ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

Enumeration; Extracellular vesicles; Flow cytometry; Nanoparticle tracking analysis; PKH67

Indexed keywords

CELL CULTURE; FLOW CYTOMETRY; NANOPARTICLES;

CURRENT DETECTION; DEGREE OF AUTOMATION; ENUMERATION; EXTRACELLULAR; FLUORESCENCE MODE; NANOPARTICLE TRACKING ANALYSIS; PATHOLOGICAL PROCESS; PKH67;

FLUORESCENCE;

NANOPARTICLE; NITRILOTRIACETIC ACID; BIOLOGICAL MARKER; FLUORESCENT DYE;

ANALYTIC METHOD; ARTICLE; AUTOMATION; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; EXOSOME; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LIGHT SCATTERING; NANOPARTICLE TRACKING ANALYSIS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; CELL COMMUNICATION; CELL TRACKING; CHEMISTRY; DRUG EFFECTS; METABOLISM; PROCEDURES; TUMOR CELL LINE;

BIOMARKERS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL TRACKING; EXTRACELLULAR VESICLES; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; NANOPARTICLES;

EID: 84961266809     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.12.370     Document Type: Article

References (29)

1. Yuana Y., Sturk A., Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev 2013, 27:31-39.
2. Witwer K.W., Buzás E.I., Bemis L.T., Bora A., Lässer C., Lötvall J., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research 2013, 2.
3. Shifrin D.A., Beckler M.D., Coffey R.J., Tyska M.J. Extracellular vesicles: communication, coercion, and conditioning. Mol Biol Cell 2013, 24:1253-1259.
4. Kleinjan A., Böing A.N., Sturk A., Nieuwland R. Microparticles in vascular disorders: How tissue factor-exposing vesicles contribute to pathology and physiology. Thromb Res 2012, 130(Supplement 1):S71-S73.
5. Chaput N., Thery C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011, 33:419-440.
6. Zwicker J.I., Liebman H.A., Bauer K.A., Caughey T., Campigotto F., Rosovsky R., et al. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol 2013, 160:530-537.
7. Thaler J., Ay C., Mackman N., Metz-Schimmerl S., Stift J., Kaider A., et al. Microparticle-associated tissue factor activity in patients with pancreatic cancer: Correlation with clinicopathological features. Eur J Clin Invest 2013, 43:277-285.
8. van Doormaal F.F., Kleinjan A., Berckmans R.J., Mackman N., Manly D., Kamphuisen P.W., et al. Coagulation activation anc microparticle-associated coagulant activity in cancer patients An exploratory prospective study. Thromb Haemost 2012, 108:160-165.
9. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Curry W.T., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
10. Trappenburg M.C., van Schilfgaarde M., Bredewold E.O., van Aalderen M.C., Spronk H.M.H., ten Cate H., et al. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy. Thromb Res 2011, 127:363-369.
11. Campello E., Spiezia L., Radu C.M., Bulato C., Castelli M., Gavasso S., et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res 2011, 127:473-477.
12. National Institutes of Health ClinicalTrials.gov accessed 14/02/2015. https://clinicaltrials.gov.
13. Barteneva N., Fasler-Kan E., Bernimoulin M., Stern J., Ponomarev E., Duckett L., et al. Circulating microparticles: square the circle. BMC Cell Biol 2013, 14:23.
14. El Andaloussi S., Mager I., Breakefield X.O., Wood M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013, 12:347-357.
15. Witwer K.W., Buzas E.I., Bemis L.T., Bora A., Lasser C., Lotvall J., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013, 2.
16. Van Der Pol E., Hoekstra A.G., Sturk A., Otto C., Van Leeuwen T.G., Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost 2010, 8:2596-2607.
17. Gyorgy B., Szabo T.G., Pasztoi M., Pal Z., Misjak P., Aradi B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011, 68:2667-2688.
18. György B., Módos K., Pállinger É., Pálóczi K., Pásztói M., Misják P., et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011, 117:e39-e48.
19. Van Der Pol E., Van Gemert M.J.C., Sturk A., Nieuwland R., Van Leeuwen T.G. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost 2012, 10:919-930.
20. Nolan J.P., Stoner S.A. A trigger channel threshold artifact in nanoparticle analysis. Cytometry A 2013, 83A:301-305.
21. van der Vlist E.J., Nolte-'t Hoen E.N.M., Stoorvogel W., Arkesteijn G.J.A., Wauben M.H.M. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protoc 2012, 7:1311-1326.
22. Nolte-'t Hoen E.N., van der Vlist E.J., Aalberts M., Mertens H.C., Bosch B.J., Bartelink W., et al. Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine 2012, 8:712-720.
23. Gercel-Taylor C., Atay S., Tullis R.H., Kesimer M., Taylor D.D. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem 2012, 428:44-53.
24. Anderson W., Kozak D., Coleman V.A., Jämting Å.K., Trau M. A comparative study of submicron particle sizing platforms: Accuracy, precision and resolution analysis of polydisperse particle size distributions. J Colloid Interface Sci 2013, 405:322-330.
25. Müller G. Novel tools for the study of cell type-specific exosomes and microvesicles. J Bioanal Biomed 2012, 4:46-60.
26. Dragovic R.A., Gardiner C., Brooks A.S., Tannetta D.S., Ferguson D.J., Hole P., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 2011, 7:780-788.
27. Gardiner C., Ferreira Y.J., Dragovic R.A., Redman C.W., Sargent I.L. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles 2013, 2.
28. Mignot G., Roux S., Thery C., Segura E., Zitvogel L. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med 2006, 10:376-388.
29. Miranda K.C., Bond D.T., McKee M., Skog J., Paunescu T.G., Da Silva N., et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 2010, 78:191-199.